Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04781335 · ClinicalTrials.gov registry record · Phase 4

"A Prospective Study of the Efficacy of Intracameral Dexamethasone (Dexycu™) Compared to Standard of Care Treatment for Post-Cataract Surgical Pain and Anterior Chamber Inflammation"

A Phase 4 study, sponsored by The Eye Institute of West Florida.

Completed
Registry status
Phase 4
Development phase
25
Enrollment target

NCT04781335 is a Phase 4 study that has completed, run by The Eye Institute of West Florida. The registered enrollment target is 25 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04781335, a Phase 4 study, has completed, sponsored by The Eye Institute of West Florida.

COMPLETED
Registry status
Phase 4
Development phase
25 participants
Enrollment target

Study Summary

Cataract surgery is the most common surgical procedure performed on humans today. The postoperative regimen includes a combination of steroids, NSAIDs (non-steroidal anti-inflammatory drugs) and antibiotics. Those are used to decrease the possibility of infection, inflammation that may lead to corneal and macular edema and pain management. There are several FDA approved agents either for topical use as single drug delivery or combination solutions for topical use as well; furthermore, there are slow release vehicles that may be placed at the time of surgery or postoperatively (at the lower punctum). The latter provides a less intense and demanding drop schedule and may improve patient compliance.

Interventions

  • DRUG Dexycu
  • DRUG Standard of Care post operative eye drops (steroid, antibiotic, NSAID)

Trial Details

FieldValue
Enrollment Target 25 participants
Start Date 2020-02-20
Est. Completion 2022-12-22
Phase Phase 4

What the Registry Record Tells You About NCT04781335

The ClinicalTrials.gov registry entry for NCT04781335 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Eye Institute of West Florida, which has 3 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Dexycu is the first listed.

NCT04781335 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04781335 about?

NCT04781335 is a clinical study titled ""A Prospective Study of the Efficacy of Intracameral Dexamethasone (Dexycu™) Compared to Standard of Care Treatment for Post-Cataract Surgical Pain and Anterior Chamber Inflammation"". Cataract surgery is the most common surgical procedure performed on humans today. The postoperative regimen includes a combination of steroids, NSAIDs (non-steroidal anti-inflammatory drugs) and antibiotics. Those are used to decrease the possibility of infection, inflammation that may lead to corne...

What is the current status of trial NCT04781335?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 25 participants. The study started on 2020-02-20. Estimated completion is 2022-12-22.

What interventions are being tested in trial NCT04781335?

The interventions under investigation include: Dexycu (DRUG), Standard of Care post operative eye drops (steroid, antibiotic, NSAID) (DRUG).

Who is sponsoring clinical trial NCT04781335?

This trial is sponsored by The Eye Institute of West Florida, which has 3 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.